Trial
NCT05017610
Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
National Cancer Institute (NCI)
Condition
Recurrent Glioblastoma
Intervention
Liothyronine
Why stopped
Per the PI-slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-02